Dryice Myxalytics

17 CVEs product

Monthly

CVE-2025-52656 HIGH This Week

HCL MyXalytics: 6.6.  is affected by Mass Assignment vulnerability. Mass Assignment occurs when user input is automatically bound to application objects without proper validation or access controls, potentially allowing unauthorized modification of sensitive fields.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
7.6
EPSS
0.1%
CVE-2025-52654 MEDIUM This Month

HCL MyXalytics v6.6 is affected by an HTML Injection. This issue occurs when untrusted input is included in the output without proper handling, potentially allowing unauthorized content injection and manipulation.

XSS Dryice Myxalytics
NVD
CVSS 3.1
4.6
EPSS
0.0%
CVE-2025-52653 HIGH This Week

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

XSS Dryice Myxalytics
NVD
CVSS 3.1
7.6
EPSS
0.0%
CVE-2024-42178 LOW Monitor

HCL MyXalytics is affected by a failure to restrict URL access vulnerability. Rated low severity (CVSS 2.5). No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
2.5
EPSS
0.2%
CVE-2024-42177 LOW Monitor

HCL MyXalytics is affected by SSL∕TLS Protocol affected with BREACH & LUCKY13 vulnerabilities. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
2.6
EPSS
0.1%
CVE-2024-42176 LOW Monitor

HCL MyXalytics is affected by concurrent login vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
2.6
EPSS
0.1%
CVE-2024-42181 LOW Monitor

HCL MyXalytics is affected by a cleartext transmission of sensitive information vulnerability. Rated low severity (CVSS 1.6). No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
1.6
EPSS
0.1%
CVE-2024-42180 LOW Monitor

HCL MyXalytics is affected by a malicious file upload vulnerability. Rated low severity (CVSS 1.6). No vendor patch available.

File Upload Dryice Myxalytics
NVD
CVSS 3.1
1.6
EPSS
0.2%
CVE-2024-42179 LOW Monitor

HCL MyXalytics is affected by sensitive information disclosure vulnerability. Rated low severity (CVSS 2.0), this vulnerability is remotely exploitable. No vendor patch available.

Microsoft Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
2.0
EPSS
0.2%
CVE-2024-42175 LOW Monitor

HCL MyXalytics is affected by a weak input validation vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Buffer Overflow XSS SQLi Dryice Myxalytics
NVD
CVSS 3.1
2.6
EPSS
0.2%
CVE-2024-42174 LOW Monitor

HCL MyXalytics is affected by username enumeration vulnerability. Rated low severity (CVSS 3.7), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
3.7
EPSS
0.3%
CVE-2024-42173 MEDIUM Monitor

HCL MyXalytics is affected by an improper password policy implementation vulnerability. Rated medium severity (CVSS 4.8), this vulnerability is remotely exploitable. No vendor patch available.

Brute Force Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
4.8
EPSS
0.2%
CVE-2024-42172 MEDIUM This Month

HCL MyXalytics is affected by broken authentication. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
5.3
EPSS
0.2%
CVE-2024-42171 MEDIUM This Month

HCL MyXalytics is affected by a session fixation vulnerability. Rated medium severity (CVSS 6.4), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Session Fixation Dryice Myxalytics
NVD
CVSS 3.1
6.4
EPSS
0.2%
CVE-2024-42170 MEDIUM This Month

HCL MyXalytics is affected by a session fixation vulnerability. Rated medium severity (CVSS 6.8), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Session Fixation Dryice Myxalytics
NVD
CVSS 3.1
6.8
EPSS
0.2%
CVE-2024-42169 HIGH This Month

HCL MyXalytics is affected by insecure direct object references. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
7.1
EPSS
0.3%
CVE-2024-42168 HIGH This Month

HCL MyXalytics is affected by out-of-band resource load (HTTP) vulnerability. Rated high severity (CVSS 8.9), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
8.9
EPSS
0.3%
CVE-2025-52656
EPSS 0% CVSS 7.6
HIGH This Week

HCL MyXalytics: 6.6.  is affected by Mass Assignment vulnerability. Mass Assignment occurs when user input is automatically bound to application objects without proper validation or access controls, potentially allowing unauthorized modification of sensitive fields.

Information Disclosure Dryice Myxalytics
NVD
CVE-2025-52654
EPSS 0% CVSS 4.6
MEDIUM This Month

HCL MyXalytics v6.6 is affected by an HTML Injection. This issue occurs when untrusted input is included in the output without proper handling, potentially allowing unauthorized content injection and manipulation.

XSS Dryice Myxalytics
NVD
CVE-2025-52653
EPSS 0% CVSS 7.6
HIGH This Week

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

XSS Dryice Myxalytics
NVD
CVE-2024-42178
EPSS 0% CVSS 2.5
LOW Monitor

HCL MyXalytics is affected by a failure to restrict URL access vulnerability. Rated low severity (CVSS 2.5). No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVE-2024-42177
EPSS 0% CVSS 2.6
LOW Monitor

HCL MyXalytics is affected by SSL∕TLS Protocol affected with BREACH & LUCKY13 vulnerabilities. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVE-2024-42176
EPSS 0% CVSS 2.6
LOW Monitor

HCL MyXalytics is affected by concurrent login vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVE-2024-42181
EPSS 0% CVSS 1.6
LOW Monitor

HCL MyXalytics is affected by a cleartext transmission of sensitive information vulnerability. Rated low severity (CVSS 1.6). No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVE-2024-42180
EPSS 0% CVSS 1.6
LOW Monitor

HCL MyXalytics is affected by a malicious file upload vulnerability. Rated low severity (CVSS 1.6). No vendor patch available.

File Upload Dryice Myxalytics
NVD
CVE-2024-42179
EPSS 0% CVSS 2.0
LOW Monitor

HCL MyXalytics is affected by sensitive information disclosure vulnerability. Rated low severity (CVSS 2.0), this vulnerability is remotely exploitable. No vendor patch available.

Microsoft Information Disclosure Dryice Myxalytics
NVD
CVE-2024-42175
EPSS 0% CVSS 2.6
LOW Monitor

HCL MyXalytics is affected by a weak input validation vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Buffer Overflow XSS SQLi +1
NVD
CVE-2024-42174
EPSS 0% CVSS 3.7
LOW Monitor

HCL MyXalytics is affected by username enumeration vulnerability. Rated low severity (CVSS 3.7), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVE-2024-42173
EPSS 0% CVSS 4.8
MEDIUM Monitor

HCL MyXalytics is affected by an improper password policy implementation vulnerability. Rated medium severity (CVSS 4.8), this vulnerability is remotely exploitable. No vendor patch available.

Brute Force Information Disclosure Dryice Myxalytics
NVD
CVE-2024-42172
EPSS 0% CVSS 5.3
MEDIUM This Month

HCL MyXalytics is affected by broken authentication. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVE-2024-42171
EPSS 0% CVSS 6.4
MEDIUM This Month

HCL MyXalytics is affected by a session fixation vulnerability. Rated medium severity (CVSS 6.4), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Session Fixation Dryice Myxalytics
NVD
CVE-2024-42170
EPSS 0% CVSS 6.8
MEDIUM This Month

HCL MyXalytics is affected by a session fixation vulnerability. Rated medium severity (CVSS 6.8), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Session Fixation Dryice Myxalytics
NVD
CVE-2024-42169
EPSS 0% CVSS 7.1
HIGH This Month

HCL MyXalytics is affected by insecure direct object references. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVE-2024-42168
EPSS 0% CVSS 8.9
HIGH This Month

HCL MyXalytics is affected by out-of-band resource load (HTTP) vulnerability. Rated high severity (CVSS 8.9), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy